Events

Innovating Novel Combination Therapies & Maximising Preclinical & Clinical Development to Improve Glioblastoma Targeting & Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need The glioblastoma drug development space has been energized by Merck’s acquisition of Modifi Bio last December. This landmark deal has sparked renewed hope in a field long challenged […]

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting […]

ESTRO 2025 focused on transformative innovation through partnership, via collaboration within our Radiation Oncology Community and especially with our scientific friends and partners from basic science, translational research and multidisciplinary cancer care. This journey will be continued, aiming to stay at the forefront of innovation. ESTRO 2026 will broach the opportunities to innovate our discipline […]

The 2026 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide. The meeting program will be available to view in December. Your all-access pass to the most clinically relevant cancer science. #ASCO26 session highlights include: Plenary Session, featuring the […]

The 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) will be held in Rome (Italy). Rome is the capital of Italy and one of the most important and fascinating cities in the world. Founded, according to legend, in 753 BC, it was the center of the Roman Empire, becoming the heart of one […]